Jefferies Financial Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Jefferies Financial Group’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$362K	Sell	3,315 -24,706	-88%	-$2.56M	﹤0.01%	1325
2026 Q1	$2.91M	Buy	28,021 +24,929	+806%	+$2.66M	0.02%	489
2025 Q4	$319K	Sell	3,092 -796	-20%	-$77.4K	﹤0.01%	1482
2025 Q3	$351K	Buy	3,888 +626	+19%	+$54.8K	﹤0.01%	1170
2025 Q2	$287K	Buy	+3,262	New	+$283K	﹤0.01%	1044
2024 Q4	–	Sell	-3,340	Closed	-$317K	–	1787
2024 Q3	$317K	Buy	3,340 +388	+13%	+$36.8K	﹤0.01%	1102
2024 Q2	$270K	Buy	+2,952	New	+$264K	﹤0.01%	1140

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.85% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Jefferies Financial Group's PPH Position: Q2 2026 in Review

Jefferies Financial Group reduced its VanEck Pharmaceutical ETF (PPH) stake by 88% in Q2 2026, selling an estimated $2.56M and leaving 3,315 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #1325.

Jefferies Financial Group first reported a position in PPH in Q2 2024 and has held it in 7 quarters since. The position peaked at $2.91M in Q1 2026. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Jefferies Financial Group held 3,315 shares of VanEck Pharmaceutical ETF worth $362K as of Q2 2026.
Jefferies Financial Group sold 24,706 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $2.56M.
VanEck Pharmaceutical ETF made up ﹤0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #1325 holding.
Jefferies Financial Group first reported a position in VanEck Pharmaceutical ETF in Q2 2024 and has held it in 7 quarters since.
Jefferies Financial Group's VanEck Pharmaceutical ETF position peaked at $2.91M in Q1 2026.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.